JP2022534501A5 - - Google Patents

Info

Publication number
JP2022534501A5
JP2022534501A5 JP2021570378A JP2021570378A JP2022534501A5 JP 2022534501 A5 JP2022534501 A5 JP 2022534501A5 JP 2021570378 A JP2021570378 A JP 2021570378A JP 2021570378 A JP2021570378 A JP 2021570378A JP 2022534501 A5 JP2022534501 A5 JP 2022534501A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
unsubstituted
compound according
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/034746 external-priority patent/WO2020243199A1/en
Publication of JP2022534501A publication Critical patent/JP2022534501A/ja
Publication of JP2022534501A5 publication Critical patent/JP2022534501A5/ja
Pending legal-status Critical Current

Links

JP2021570378A 2019-05-30 2020-05-27 三環式化合物 Pending JP2022534501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962854597P 2019-05-30 2019-05-30
US62/854,597 2019-05-30
PCT/US2020/034746 WO2020243199A1 (en) 2019-05-30 2020-05-27 Tricyclic compounds

Publications (2)

Publication Number Publication Date
JP2022534501A JP2022534501A (ja) 2022-08-01
JP2022534501A5 true JP2022534501A5 (https=) 2023-05-30

Family

ID=73552666

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570378A Pending JP2022534501A (ja) 2019-05-30 2020-05-27 三環式化合物

Country Status (19)

Country Link
US (1) US11136321B2 (https=)
EP (1) EP3976618A4 (https=)
JP (1) JP2022534501A (https=)
KR (1) KR20220016177A (https=)
CN (1) CN113906029A (https=)
AU (1) AU2020282707B2 (https=)
BR (1) BR112021023967A2 (https=)
CA (1) CA3138938A1 (https=)
CL (1) CL2021003139A1 (https=)
CO (1) CO2021017202A2 (https=)
EA (1) EA202192760A1 (https=)
IL (1) IL287813A (https=)
MA (1) MA56058A (https=)
MX (1) MX2021014458A (https=)
PE (1) PE20220427A1 (https=)
PH (1) PH12021552953A1 (https=)
SG (1) SG11202113214QA (https=)
TW (1) TW202110845A (https=)
WO (1) WO2020243199A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220000874A1 (en) * 2019-05-30 2022-01-06 Aligos Therapeutics, Inc. Tricyclic compounds
TWI886184B (zh) * 2019-12-10 2025-06-11 大陸商上海翰森生物醫藥科技有限公司 含吡唑多環類衍生物抑制劑、其製備方法和應用
GB202103704D0 (en) * 2021-03-17 2021-04-28 Pathios Therapeutics Ltd Compounds
EP4251625A4 (en) * 2020-11-24 2024-10-09 Aligos Therapeutics, Inc. Tricyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701273D0 (en) * 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
WO2008157273A1 (en) * 2007-06-14 2008-12-24 Smithkline Beecham Corporation Chemical compounds
AU2013404035B2 (en) * 2013-10-29 2017-04-20 Medivir Ab Quinazoline based respiratory syncytial virus inhibitors
CO2018009382A2 (es) 2016-03-09 2018-09-20 Univ Emory Eliminación del virus de la hepatitis b con agentes antivirales
CN110066278B (zh) * 2017-06-01 2021-06-08 广东东阳光药业有限公司 稠合三环类化合物及其在药物中的应用

Similar Documents

Publication Publication Date Title
JP2022534501A5 (https=)
JP2022529466A5 (https=)
JP2022522312A5 (https=)
EP3317286B1 (en) Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
EP1667694B1 (en) Tlr7 ligands for the treatment of hepatitis c
EP2997019B1 (en) Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
KR102666477B1 (ko) 글루타민 유사체의 프로드럭
US11001564B2 (en) Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
ES2989915T3 (es) Compuestos macrocíclicos como agonistas de STING y métodos y usos de los mismos
EP3759083B1 (en) 2,4-diaminoquinazoline derivatives and use thereof in the treatment of virus infections, cancer or allergies
JP2010514768A5 (https=)
RU2006109491A (ru) Новые трициклические нуклеозиды или нуклеотиды в качестве терапевтических средств
JP2011518168A5 (https=)
SK4742001A3 (en) Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
WO2008056264A3 (en) Novel nucleotide analogues as percursor molecules for antivirals
RU2007118729A (ru) Пуриновые производные для применения в качестве агонистов аденозинового рецептора а-2а
JP2022519764A5 (https=)
AU2018391977A1 (en) Isoxazole compounds for the treatment of diseases associated with HBV infections
ZA200105702B (en) Antiviral nucleoside analogues.
ES2962269T3 (es) Análogos de nucleósidos alquinil como inhibidores del rinovirus humano
JP2007509052A5 (https=)
JP2004182725A5 (https=)
AU2017335205A1 (en) Pyrimidine prodrugs for the treatment of viral infections and further diseases
WO2025207435A1 (en) 2'-fluoro-6'-methylene carbocyclic nucleos(t)ides as potent antiviral agents for the treatment of wild-type and mutant hepatitis b virus (hbv) infections
EP4686470A1 (en) Macrocyclic peptidomimetics as antiviral agents